This report demonstrates that LoNA is upregulated in APP/PS1 transgenic mice, and a reduction of LoNA levels in the hippocampus of these mice rescues their learning and memory deficits, illustrating that LoNA is implicated in neurological diseases and may provide a novel avenue for treatment of neurodegenerative disorders. This evidence concerns the gene APP and nervous system disorder.